Castro, Marjorie B.

HRN: 29-33-98  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2026
CEFTRIAXONE 1G (VIAL)
07/21/2026
07/28/2026
IVT
2g As LD Then 1g Q12
Q12
Complicated UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: